The DRAGON study: biologic DRug survivAl in PortuGuese psOriasis patieNts

Eur J Dermatol. 2018 Oct 1;28(5):685-687. doi: 10.1684/ejd.2018.3353.
No abstract available

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adalimumab / therapeutic use
  • Adult
  • Biological Products / therapeutic use*
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Etanercept / therapeutic use
  • Female
  • Humans
  • Infliximab / therapeutic use
  • Male
  • Middle Aged
  • Portugal
  • Psoriasis / diagnosis*
  • Psoriasis / drug therapy*
  • Quality of Life*
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Ustekinumab / therapeutic use
  • Young Adult

Substances

  • Biological Products
  • Infliximab
  • Ustekinumab
  • Adalimumab
  • Etanercept